Roche to pay up to $489 mln for next generation antibody firm
December 18, 2014 at 12:24 PM EST
Dec 18 (Reuters) - Switzerland's Roche said on Thursday it had agreed to pay up to $489 million to acquire Austrian biotech company Dutalys, a specialist in the discovery and development of so-called bi-specific antibodies.
